 "Wockhardt reports Q1 net loss at Rs 75 cr as revenue from UK, US declines")
Pharmaceutical firm Wockhardt Ltd on Friday reported a widening of consolidated net loss at Rs 75 crore in the first quarter ended June as revenue from key markets of the UK and the US declined.
The company had posted a consolidated net loss of Rs 7 crore in the same quarter last fiscal, Wockhardt Ltd said in a regulatory filing.
Consolidated revenue from operations were at Rs 595 crore during the period under review, down from Rs 860 crore last year.
UK business revenue stood at Rs 196 crore in the first quarter as against Rs 407 crore in the preceding fiscal. Similarly, US business also posted lower revenue at Rs 74 crore from Rs 102 crore a year ago, impacted by price erosion and supply disruptions.
However, revenue from Indian operations was at Rs 158 crore, a growth of 4 per cent in comparison to the year-ago quarter, it said.
Total expenses were lower at Rs 748 crore. The same stood at Rs 880 crore previous year.
Wockhardt said it filed seven patents during the quarter and one was granted, taking its total patents to 804.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app